Convalescent plasma is a promising therapy for coronavirus disease 2019 (COVID-19), but
its efficacy in intensive care unit (ICU) patients in low-and middle-income country settings …

There have been several efforts to minimize the effects caused by the COVID-19 virus
around the world. Vaccines were developed in record time and alternative therapies were …

Epidemics are a serious public health threat, and the resources for mitigating their effects
are typically limited. Decision-makers face challenges in forecasting the supply and demand …

Abstract Introduction: Covid Convalescent Plasma (CCP) failed to demonstrate its efficacy in
severe and life-threatening coronavirus disease 2019 (COVID-19) cases. However, the role …

In general, there are three categories of specimens from patients with EVD:(1) Persons
under investigation (PUI), who are patients with symptoms consistent with EVD and a …

Method A cross-sectional study measuring the perceptions of Saudis toward participating in
the COVID-19 Convalescent Plasma Clinical Trial was conducted with participants who had …

Abstract In West Africa, the Ebola virus disease (EVD) outbreak between 2013 and 2016 is
considered as one of the deadliest re-emerging viruses, which began after human contact …

Currently, there is no availability of any proven specific treatment or prevention strategy to
fight against COVID-19. Convalescent plasma (CP) therapy is expected to increase survival …